Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of plasminogen activator inhibitor-1 as a biomarker of unplanned revascularization and major adverse cardiac events in coronary angiography and percutaneous coronary intervention.
Jung RG, Simard T, Di Santo P, Dhaliwal S, Sypkes C, Duchez AC, Moreland R, Taylor K, Parlow S, Visintini S, Labinaz A, Marbach J, Sarathy K, Bernick J, Joseph J, Boland P, Abdel-Razek O, Harnett DT, Ramirez FD, Hibbert B. Jung RG, et al. Among authors: boland p. Thromb Res. 2020 Jul;191:125-133. doi: 10.1016/j.thromres.2020.04.025. Epub 2020 Apr 24. Thromb Res. 2020. PMID: 32447094
Physician prediction of 1-year mortality in the cardiac catheterization laboratory: comparison to a validated risk score.
Sarathy K, Jung RG, Simard T, Parlow S, Di Santo P, Moreland R, Jung Y, Abdel-Razek O, Boland P, Russo JJ, Chong AY, So D, Froeschl M, Dick A, Glover C, Labinaz M, Le May M, Hibbert B. Sarathy K, et al. Among authors: boland p. Coron Artery Dis. 2021 Aug 1;32(5):403-410. doi: 10.1097/MCA.0000000000000967. Coron Artery Dis. 2021. PMID: 33060527
Performance of Plasma Adenosine as a Biomarker for Predicting Cardiovascular Risk.
Simard T, Jung RG, Di Santo P, Ramirez FD, Labinaz A, Gaudet C, Motazedian P, Parlow S, Joseph J, Moreland R, Marbach J, Boland P, Promislow S, Russo JJ, Chong AY, So D, Froeschl M, Le May M, Hibbert B. Simard T, et al. Among authors: boland p. Clin Transl Sci. 2021 Jan;14(1):354-361. doi: 10.1111/cts.12886. Epub 2020 Dec 2. Clin Transl Sci. 2021. PMID: 33264483 Free PMC article.
Modifiable Risk Factors and Residual Risk Following Coronary Revascularization: Insights From a Regionalized Dedicated Follow-Up Clinic.
Simard T, Jung RG, Di Santo P, Harnett DT, Abdel-Razek O, Ramirez FD, Motazedian P, Parlow S, Labinaz A, Moreland R, Marbach J, Poulin A, Levi A, Majeed K, Boland P, Couture E, Sarathy K, Promislow S, Russo JJ, Chong AY, So D, Froeschl M, Dick A, Labinaz M, Le May M, Holmes DR Jr, Hibbert B. Simard T, et al. Among authors: boland p. Mayo Clin Proc Innov Qual Outcomes. 2021 Dec 4;5(6):1138-1152. doi: 10.1016/j.mayocpiqo.2021.09.001. eCollection 2021 Dec. Mayo Clin Proc Innov Qual Outcomes. 2021. PMID: 34934904 Free PMC article.
Adenosine as a Marker and Mediator of Cardiovascular Homeostasis: A Translational Perspective.
Simard T, Jung R, Labinaz A, Faraz MA, Ramirez FD, Di Santo P, Pitcher I, Motazedian P, Gaudet C, Rochman R, Marbach J, Boland P, Sarathy K, Alghofaili S, Russo JJ, Couture E, Beanlands RS, Hibbert B. Simard T, et al. Among authors: boland p. Cardiovasc Hematol Disord Drug Targets. 2019;19(2):109-131. doi: 10.2174/1871529X18666181011103719. Cardiovasc Hematol Disord Drug Targets. 2019. PMID: 30318008
Evaluation of Plasma Adenosine as a Marker of Cardiovascular Risk: Analytical and Biological Considerations.
Simard T, Jung R, Labinaz A, Faraz MA, Ramirez FD, Di Santo P, Perry-Nguyen D, Pitcher I, Motazedian P, Gaudet C, Rochman R, Marbach J, Boland P, Sarathy K, Alghofaili S, Russo JJ, Couture E, Promislow S, Beanlands RS, Hibbert B. Simard T, et al. Among authors: boland p. J Am Heart Assoc. 2019 Aug 6;8(15):e012228. doi: 10.1161/JAHA.119.012228. Epub 2019 Aug 5. J Am Heart Assoc. 2019. PMID: 31379241 Free PMC article.
Transradial Versus Transfemoral Access for Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis.
Di Santo P, Simard T, Wells GA, Jung RG, Ramirez FD, Boland P, Marbach JA, Parlow S, Kyeremanteng K, Coyle D, Fergusson D, Russo JJ, Chong AY, Froeschl M, So DY, Dick A, Glover C, Labinaz M, Hibbert B, Le May M. Di Santo P, et al. Among authors: boland p. Circ Cardiovasc Interv. 2021 Mar;14(3):e009994. doi: 10.1161/CIRCINTERVENTIONS.120.009994. Epub 2021 Mar 9. Circ Cardiovasc Interv. 2021. PMID: 33685220
Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y12 receptor antagonist for acute coronary syndromes: Insights on timing of discontinuation of ticagrelor and clopidogrel prior to surgery.
Russo JJ, James TE, Ruel M, Dupuis JY, Singh K, Goubran D, Malhotra N, Rubens F, Chong AY, Hibbert B, Boland P, Tran DT, Tanguay JF, Lordkipanidzé M, Perrault L, Wells GA, Bourke M, Chan V, So DY. Russo JJ, et al. Among authors: boland p. Eur Heart J Acute Cardiovasc Care. 2019 Sep;8(6):543-553. doi: 10.1177/2048872617740832. Epub 2018 Jan 9. Eur Heart J Acute Cardiovasc Care. 2019. PMID: 29313713
355 results